Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?

被引:0
作者
Satyanarayanan, Senthil Kumaran [1 ]
Yip, Tsz Fung [2 ]
Han, Zixu [1 ]
Zhu, Huachen [2 ]
Qin, Dajiang [1 ,3 ,4 ]
Lee, Suki Man Yan [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Hong Kong Inst Sci & Innovat, Ctr Regenerat Med & Hlth, Hong Kong Sci Pk, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China
[3] Guangzhou Med Univ, Guangdong Higher Educ Inst, Key Lab Biol Targeting Diag Therapy & Rehabil, Affiliated Hosp 5, Guangzhou, Peoples R China
[4] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China
关键词
toll-like receptors (TLRs); neurodegenerative disorders; post-COVID-19; syndrome; neuroinflammation; SARS-CoV-2; PATTERN-RECOGNITION RECEPTORS; PARKINSONS-DISEASE; NEUROLOGICAL MANIFESTATIONS; SIGNALING PATHWAY; ALPHA-SYNUCLEIN; INNATE IMMUNITY; COVID-19; SARS-COV-2; BRAIN; POLYMORPHISMS;
D O I
10.3389/fmed.2025.1458281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the intricate realm of interactions between hosts and pathogens, Toll-like receptors (TLRs), which play a crucial role in the innate immune response, possess the ability to identify specific molecular signatures. This includes components originating from pathogens such as SARS-CoV-2, as well as the resulting damage-associated molecular patterns (DAMPs), the endogenous molecules released after cellular damage. A developing perspective suggests that TLRs play a central role in neuroinflammation, a fundamental factor in neurodegenerative conditions like Alzheimer's and Parkinson's disease (PD). This comprehensive review consolidates current research investigating the potential interplay between TLRs, their signaling mechanisms, and the processes of neurodegeneration following SARS-CoV-2 infection with an aim to elucidate the involvement of TLRs in the long-term neurological complications of COVID-19 and explore the potential of targeting TLRs as a means of implementing intervention strategies for the prevention or treatment of COVID-19-associated long-term brain outcomes.
引用
收藏
页数:19
相关论文
共 238 条
[1]   Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3+T cells from COVID-19 patients [J].
Abdolmohammadi-Vahid, Samaneh ;
Baradaran, Behzad ;
Sadeghi, Armin ;
Bezemer, Gillina F. G. ;
Kiaee, Fatemeh ;
Adcock, Ian M. ;
Folkerts, Gert ;
Garssen, Johan ;
Mortaz, Esmaeil .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2024, 137
[2]   Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant [J].
Abhyankar, Mayuresh M. ;
Mann, Barbara J. ;
Sturek, Jeffrey M. ;
Brovero, Savannah ;
Moreau, G. Brett ;
Sengar, Anjali ;
Richardson, Crystal M. ;
Agah, Sayeh ;
Pomes, Anna ;
Kasson, Peter M. ;
Tomai, Mark A. ;
Fox, Christopher B. ;
Petri, William A., Jr. .
NPJ VACCINES, 2021, 6 (01)
[3]   The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets [J].
Adamu, Alhamdu ;
Li, Shuo ;
Gao, Fankai ;
Xue, Guofang .
FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
[4]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[5]   SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19 [J].
Aktar, Salma ;
Amin, Saiful .
VIRUS RESEARCH, 2023, 323
[6]   SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein [J].
Albornoz, Eduardo A. ;
Amarilla, Alberto A. ;
Modhiran, Naphak ;
Parker, Sandra ;
Li, Xaria X. ;
Wijesundara, Danushka K. ;
Aguado, Julio ;
Zamora, Adriana Pliego ;
McMillan, Christopher L. D. ;
Liang, Benjamin ;
Peng, Nias Y. G. ;
Sng, Julian D. J. ;
Saima, Fatema Tuj ;
Fung, Jenny N. ;
Lee, John D. ;
Paramitha, Devina ;
Parry, Rhys ;
Avumegah, Michael S. ;
Isaacs, Ariel ;
Lo, Martin W. ;
Miranda-Chacon, Zaray ;
Bradshaw, Daniella ;
Salinas-Rebolledo, Constanza ;
Rajapakse, Niwanthi W. ;
Wolvetang, Ernst J. ;
Munro, Trent P. ;
Rojas-Fernandez, Alejandro ;
Young, Paul R. ;
Stacey, Katryn J. ;
Khromykh, Alexander A. ;
Chappell, Keith J. ;
Watterson, Daniel ;
Woodruff, Trent M. .
MOLECULAR PSYCHIATRY, 2023, 28 (07) :2878-2893
[7]   Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis [J].
Alhabibi, Alshaymaa M. ;
Hassan, Asmaa S. ;
Abd Elbaky, Nashwa Mohamed ;
Eid, Hoda Asaad ;
Khalifa, Mohie Aldeen Abd Alzaher ;
Wahab, Maisa A. ;
Althoqapy, Azza Ali ;
Abdou, Aml E. ;
Zakaria, Doaa Mohammed ;
Nassef, Eman Mostafa ;
Kasim, Sammar Ahmed ;
Saleh, Ola, I ;
Elsheikh, Asmaa Abdelghany ;
Lotfy, Mahmoud ;
Sayed, Alaa .
JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 :665-675
[8]   Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish Population [J].
Ali, Hussein N. ;
Niranji, Sherko S. ;
Al-Jaf, Sirwan M. A. .
HUMAN GENE, 2022, 34
[9]   Neuroinflammation and Its Impact on the Pathogenesis of COVID-19 [J].
Almutairi, Mohammed M. ;
Sivandzade, Farzane ;
Albekairi, Thamer H. ;
Alqahtani, Faleh ;
Cucullo, Luca .
FRONTIERS IN MEDICINE, 2021, 8
[10]   Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study [J].
Alseoudy, Mahmoud M. ;
Elgamal, Mohamed ;
Abdelghany, Dalia A. ;
Borg, Asmaa M. ;
El-Mesery, Ahmed ;
Elzeiny, Dina ;
Hammad, Maha O. .
CLINICAL IMMUNOLOGY, 2022, 235